Tech Company Financing Transactions
Receptor BioLogix Funding Round
On 9/30/2008, Receptor BioLogix secured $1 million in funding from EW Healthcare Partners, New Science Ventures and private investors.
Transaction Overview
Company Name
Announced On
9/30/2008
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Undisclosed
Investors
EW Healthcare Partners (Jeffrey Himawan)
New Science Ventures (Somu Subramaniam)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
PO Box 1210
Mountain View, CA 94042
USA
Mountain View, CA 94042
USA
Phone
Website
Email Address
Overview
Receptor BioLogix Inc., a biopharmaceutical company focused on developing newly discovered protein therapeutics to treat cancer, autoimmune, metabolic and other diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Janet Swearson
Browse more venture capital transactions:
Prev: 9/30/2008: Raydiance venture capital transaction
Next: 9/30/2008: Voltage Security venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs